Get started
Author

Lenka Kašíková

Observed names: Kasikova, Lenka, Kašíková, Lenka, L. Kasikova, Lenka Kasikova
ORCID: 0000-0002-4604-4821
Observed ORCID: 0000-0002-4604-4821
OpenAlex ID: A5004954459
Detection of immunogenic cell death and its relevance for cancer therapy
2020 · Jitka Fucikova, Oliver Kepp, et al. · Cell Death and Disease · 1,207
PDF
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
2018 · Iva Truxova, Lenka Kasikova, et al. · Journal for ImmunoTherapy of Cancer · 202
PDF
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
2016 · Jitka Fucikova, Iva Truxova, et al. · Blood · 141
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
2024 · Lenka Kasikova, Jana Rakova, et al. · Nature Communications · 121
PDF
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
2019 · Jitka Fucikova, Jana Rakova, et al. · Clinical Cancer Research · 121
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
2020 · Michal Hensler, Lenka Kasikova, et al. · Journal for ImmunoTherapy of Cancer · 116
PDF
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
2019 · Lenka Kasikova, Michal Hensler, et al. · Journal for ImmunoTherapy of Cancer · 83
PDF
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
2021 · Jana Rakova, Iva Truxova, et al. · OncoImmunology · 63
Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer
2017 · Jitka Fucikova, Lenka Kasikova, et al. · Immunology Letters · 58
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
2022 · Jitka Fucikova, Michal Hensler, et al. · Clinical Cancer Research · 57
PDF
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
2019 · Iva Truxova, Lenka Kasikova, et al. · Haematologica · 56
PDF
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer
2024 · Tereza Lanickova, Michal Hensler, et al. · Clinical Cancer Research · 40
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
2023 · Peter Holicek, Iva Truxova, et al. · Cell Death and Disease · 32
PDF
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
2022 · Jitka Fucikova, Lenka Palova-Jelinkova, et al. · Trends in cancer · 32
PDF
Genomic Structure of Hstx2 Modifier of Prdm9 -Dependent Hybrid Male Sterility in Mice
2019 · Diana Lustyk, Slavomír Kinský, et al. · Genetics · 26
PDF
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
2022 · Michal Hensler, Jana Rakova, et al. · OncoImmunology · 17
PDF
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma
2026 · Tereza Lanickova, Artemis Angelidou, et al. · Nature Communications · 6
PDF
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
2019 · Lenka Kasikova, Iva Truxova, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 3
Supplementary Figure from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
2023 · Jitka Fucikova, Michal Hensler, et al. · 1
PDF
Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood
2019 · Peter Holicek, Iva Truxova, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1
756 PD-L1 + macrophages impair immune organization by disrupting tertiary lymphoid structures in ovarian cancer metastases
2026 · Lenka Kasikova, Ema Zacharova, et al. · Journal for ImmunoTherapy of Cancer
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer
2026 · Kathrin B. Labrosse, Flavio C. Lombardo, et al. · npj Precision Oncology
PDF
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer
2026 · Kathrin B. Labrosse, Flavio C. Lombardo, et al. · International Journal of Gynecological Cancer
429eP NKG2A inhibition promotes NK cell-CD8+ T cell interactions in support of improved anticancer immunity in ovarian carcinoma
2025 · A. Angelidou, T. Lanickova, et al. · Immuno-Oncology Technology
359P Integrative molecular and spatial analysis of intratumoral tertiary lymphoid structures: Insights into immunotherapy response
2025 · B. Tunková, L. Kasikova, et al. · Immuno-Oncology Technology
Works count: 69
Citation count: 2,383
H-index: 16
I10-index: 16
Year
Topic
Type